Medicine
Volume 36, Issue 1 , Pages 19-23 , January 2008

Principles of cytotoxic chemotherapy

References 

  1. Lind MJ, Ardiet C. Pharmacokinetics of alkylating agents. Cancer Surv. 1993;17:157–188
  2. Belani CP. Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma. Semin Oncol. 2004;31(suppl 14):25–33
  3. Walling J. From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates. Invest New Drugs. 2006;24:37–77
  4. Rose MG, Farrell MP, Schmitz JC. Thymidylate synthase: a critical target for cancer chemotherapy. Clin Colorectal Cancer. 2002;1:220–229
  5. Weiss RB. The anthracyclines: will we ever find a better doxorubicin?. Semin Oncol. 1992;9:670–686
  6. Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer. 2006;6:789–802
  7. Hamid O. Emerging treatments in oncology: focus on tyrosine kinase (erbB) receptor inhibitors. J Am Pharm Assoc. 2004;44:52–58

PII: S1357-3039(07)00344-1

doi: 10.1016/j.mpmed.2007.10.003

Medicine
Volume 36, Issue 1 , Pages 19-23 , January 2008

Article Tools

* Image Usage & Resolution